Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	fructose-bisphosphate aldolase activity	ALDOA ALDOB ALDOC	5.05e-07	3	160	3	GO:0004332
GeneOntologyMolecularFunction	fibrinogen binding	ITGB3 FBLN1 CDH5	9.92e-06	6	160	3	GO:0070051
GeneOntologyMolecularFunction	aldehyde-lyase activity	ALDOA ALDOB ALDOC	7.95e-05	11	160	3	GO:0016832
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	GABRG2 DNAJC13 PSEN1 TBC1D5 ABCC5 COPG2 GPRC5C GRIN2B MCOLN1 MYCBPAP ITGB3 NCDN SORT1 OR51E2 ARFGEF3 ARHGAP1 NDRG1 AP1G1 SYT11 PTPRS ANO6 ZDHHC13 VPS13B DGAT1 TMEM63A	2.04e-05	1307	160	25	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	GABRG2 DNAJC13 PSEN1 TBC1D5 ABCC5 COPG2 GPRC5C GRIN2B MCOLN1 MYCBPAP ITGB3 NCDN SORT1 OR51E2 ARFGEF3 ARHGAP1 NDRG1 AP1G1 SYT11 PTPRS ANO6 ZDHHC13 VPS13B DGAT1 TMEM63A	2.56e-05	1325	160	25	GO:0012506
MousePheno	abnormal sperm number	ANKRD31 RAPGEF6 CES5A TOPAZ1 NUP210L STRBP PIWIL1 LANCL1 YTHDC2 PFDN5 QRICH2 ADGB AP1G1 OSBP2 SPOCD1 VPS13B HSP90AA1	3.21e-05	624	123	17	MP:0002673
MousePheno	decreased male germ cell number	ANKRD31 RAPGEF6 CES5A TOPAZ1 NUP210L STRBP PIWIL1 LANCL1 YTHDC2 PFDN5 QRICH2 ADGB AP1G1 OSBP2 SPOCD1 VPS13B HSP90AA1	4.42e-05	640	123	17	MP:0004901
Domain	ARM-type_fold	DOCK2 CEP104 DNAJC13 DOCK9 COPG2 HEATR1 NCDN RYR3 ARFGEF3 AP1G1 ARVCF MTOR MROH2B SERAC1 GCN1 TANGO6	2.85e-08	339	157	16	IPR016024
Domain	FBA_I	ALDOA ALDOB ALDOC	5.83e-07	3	157	3	IPR000741
Domain	Glycolytic	ALDOA ALDOB ALDOC	5.83e-07	3	157	3	PF00274
Domain	Aldolase_I_AS	ALDOA ALDOB ALDOC	5.83e-07	3	157	3	IPR029768
Domain	ALDOLASE_CLASS_I	ALDOA ALDOB ALDOC	5.83e-07	3	157	3	PS00158
Domain	HEAT_REPEAT	CEP104 COPG2 HEATR1 MTOR MROH2B GCN1 TANGO6	1.99e-06	70	157	7	PS50077
Domain	-	CEP104 DNAJC13 COPG2 HEATR1 AP1G1 ARVCF MTOR MROH2B SERAC1 GCN1 TANGO6	2.86e-06	222	157	11	1.25.10.10
Domain	ARM-like	DOCK2 CEP104 DNAJC13 COPG2 HEATR1 AP1G1 ARVCF MTOR MROH2B SERAC1 GCN1 TANGO6	3.10e-06	270	157	12	IPR011989
Domain	Gln-Leu-Gln_QLQ	SMARCA2 SMARCA4	7.02e-05	2	157	2	IPR014978
Domain	SnAC	SMARCA2 SMARCA4	7.02e-05	2	157	2	PF14619
Domain	QLQ	SMARCA2 SMARCA4	7.02e-05	2	157	2	SM00951
Domain	QLQ	SMARCA2 SMARCA4	7.02e-05	2	157	2	PS51666
Domain	Presenilin	PSEN1 PSEN2	7.02e-05	2	157	2	PF01080
Domain	SnAC	SMARCA2 SMARCA4	7.02e-05	2	157	2	SM01314
Domain	Peptidase_A22A	PSEN1 PSEN2	7.02e-05	2	157	2	IPR001108
Domain	SnAC	SMARCA2 SMARCA4	7.02e-05	2	157	2	IPR029295
Domain	QLQ	SMARCA2 SMARCA4	7.02e-05	2	157	2	PF08880
Domain	HSA	SMARCA2 SMARCA4	4.17e-04	4	157	2	SM00573
Domain	HSA	SMARCA2 SMARCA4	4.17e-04	4	157	2	PS51204
Domain	HSA_dom	SMARCA2 SMARCA4	4.17e-04	4	157	2	IPR014012
Domain	HSA	SMARCA2 SMARCA4	4.17e-04	4	157	2	PF07529
Domain	RasGEFN	RAPGEF6 RASGRP1 SOS2	5.98e-04	20	157	3	SM00229
Domain	DMAP_binding	DIP2A DIP2C	6.91e-04	5	157	2	PF06464
Domain	RasGEF_N	RAPGEF6 RASGRP1 SOS2	6.93e-04	21	157	3	PF00618
Domain	Ras-like_Gua-exchang_fac_N	RAPGEF6 RASGRP1 SOS2	7.98e-04	22	157	3	IPR000651
Domain	RASGEF_NTER	RAPGEF6 RASGRP1 SOS2	7.98e-04	22	157	3	PS50212
Domain	BRK	SMARCA2 SMARCA4	1.03e-03	6	157	2	SM00592
Domain	FAST_2	FASTKD1 FASTKD3	1.03e-03	6	157	2	PF08368
Domain	RAP	FASTKD1 FASTKD3	1.03e-03	6	157	2	SM00952
Domain	DMAP1-bd	DIP2A DIP2C	1.03e-03	6	157	2	IPR010506
Domain	RAP	FASTKD1 FASTKD3	1.03e-03	6	157	2	PF08373
Domain	RAP	FASTKD1 FASTKD3	1.03e-03	6	157	2	PS51286
Domain	FAST_1	FASTKD1 FASTKD3	1.03e-03	6	157	2	PF06743
Domain	BRK_domain	SMARCA2 SMARCA4	1.03e-03	6	157	2	IPR006576
Domain	HELP	EML6 EML5	1.03e-03	6	157	2	PF03451
Domain	FAST_Leu-rich	FASTKD1 FASTKD3	1.03e-03	6	157	2	IPR010622
Domain	HELP	EML6 EML5	1.03e-03	6	157	2	IPR005108
Domain	DMAP_binding	DIP2A DIP2C	1.03e-03	6	157	2	SM01137
Domain	BRK	SMARCA2 SMARCA4	1.03e-03	6	157	2	PF07533
Domain	FAST_2	FASTKD1 FASTKD3	1.03e-03	6	157	2	IPR013579
Domain	RAP	FASTKD1 FASTKD3	1.03e-03	6	157	2	IPR013584
Domain	HEAT	CEP104 HEATR1 MTOR GCN1	1.43e-03	58	157	4	IPR000357
Domain	PSN	PSEN1 PSEN2	1.43e-03	7	157	2	SM00730
Domain	Preselin/SPP	PSEN1 PSEN2	1.43e-03	7	157	2	IPR006639
Domain	RASGEF_CAT	RAPGEF6 RASGRP1 SOS2	1.81e-03	29	157	3	PS50009
Domain	RasGEF	RAPGEF6 RASGRP1 SOS2	2.00e-03	30	157	3	PF00617
Domain	-	RAPGEF6 RASGRP1 SOS2	2.00e-03	30	157	3	1.10.840.10
Domain	RASGEF_cat_dom	RAPGEF6 RASGRP1 SOS2	2.00e-03	30	157	3	IPR001895
Domain	RasGEF	RAPGEF6 RASGRP1 SOS2	2.00e-03	30	157	3	SM00147
Domain	AMP-binding	DIP2A DIP2C ACSM2B	2.00e-03	30	157	3	PF00501
Domain	Ras_GEF_dom	RAPGEF6 RASGRP1 SOS2	2.00e-03	30	157	3	IPR023578
Domain	AMP-dep_Synth/Lig	DIP2A DIP2C ACSM2B	2.00e-03	30	157	3	IPR000873
Domain	Helicase_C	WRN YTHDC2 CHD1L SMARCA2 SMARCA4	2.10e-03	107	157	5	PF00271
Domain	HELICc	WRN YTHDC2 CHD1L SMARCA2 SMARCA4	2.10e-03	107	157	5	SM00490
Domain	Helicase_C	WRN YTHDC2 CHD1L SMARCA2 SMARCA4	2.19e-03	108	157	5	IPR001650
Domain	HELICASE_CTER	WRN YTHDC2 CHD1L SMARCA2 SMARCA4	2.28e-03	109	157	5	PS51194
Domain	HELICASE_ATP_BIND_1	WRN YTHDC2 CHD1L SMARCA2 SMARCA4	2.28e-03	109	157	5	PS51192
Domain	DEXDc	WRN YTHDC2 CHD1L SMARCA2 SMARCA4	2.28e-03	109	157	5	SM00487
Domain	Helicase_ATP-bd	WRN YTHDC2 CHD1L SMARCA2 SMARCA4	2.37e-03	110	157	5	IPR014001
Domain	SNF2_N	CHD1L SMARCA2 SMARCA4	2.42e-03	32	157	3	IPR000330
Domain	SNF2_N	CHD1L SMARCA2 SMARCA4	2.42e-03	32	157	3	PF00176
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	FRAS1 RAPGEF6 STRBP TBC1D5 LANCL1 YTHDC2 ITGB3 HNRNPF NCDN CLPTM1L DIP2A GSE1 AP1G1 ARVCF PYGB IQGAP3 TOP3A	1.29e-08	650	163	17	38777146
Pubmed	Mode of interactions of human aldolase isozymes with cytoskeletons.	ALDOA ALDOB ALDOC	1.01e-07	3	163	3	9244396
Pubmed	Aldolase positively regulates of the canonical Wnt signaling pathway.	ALDOA ALDOB ALDOC	1.01e-07	3	163	3	24993527
Pubmed	Human skeletal-muscle aldolase: N-terminal sequence analysis of CNBr- and o-iodosobenzoic acid-cleavage fragments.	ALDOA ALDOB ALDOC	1.01e-07	3	163	3	6696436
Pubmed	Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump.	ALDOA ALDOB ALDOC	4.03e-07	4	163	3	11399750
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	PSEN1 PSEN2 RYR3	1.00e-06	5	163	3	23918386
Pubmed	Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms.	PSEN1 PSEN2 APBA3	2.00e-06	6	163	3	12196555
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	NCDN ARFGEF3 AP1G1 MTOR GCN1 IQGAP3 HSP90AA1 SOS2	2.61e-06	183	163	8	23956138
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	PSEN1 RNPC3 FASTKD1 EXOSC1 COPG2 YTHDC2 PSMD8 HEATR1 WDR59 COMMD6 MTOR ANO6 EIF3H FASTKD3 GCN1	2.96e-06	754	163	15	33060197
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DNAJC13 WRN HNRNPF CLPTM1L MTOR SMARCA2 GCN1 IQGAP3	5.42e-06	202	163	8	33005030
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	STRBP EXOSC1 BCAT1 COPG2 YTHDC2 HEATR1 HNRNPF BLVRA AP1G1 MTOR SMARCA2 SMARCA4 GCN1 IQGAP3	6.44e-06	704	163	14	29955894
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DNAJC13 TBC1D5 HIPK2 CHD1L TEP1 SLC25A37 HNRNPF NCDN OR51E2 ARFGEF3 NDRG1 PTPRS SMARCA2 DIP2C PRKD1 NQO2 ZDHHC13 VPS13B ADGRD1 TMEM63A SOS2	6.97e-06	1489	163	21	28611215
Pubmed	Defining the membrane proteome of NK cells.	DOCK2 DNAJC13 PSEN2 DOCK9 HEATR1 HNRNPF NCDN CLPTM1L AP1G1 MTOR ANO6 SMARCA4 PYGB EIF3H ALDOA ZDHHC13 GCN1 HSP90AA1	1.03e-05	1168	163	18	19946888
Pubmed	Presenilin/γ-secretase-dependent EphA3 processing mediates axon elongation through non-muscle myosin IIA.	PSEN1 PSEN2 HSP90AA1	1.62e-05	11	163	3	31577226
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FRAS1 RAPGEF6 DOCK9 PLXND1 TEP1 FBXO46 WDR59 DIP2A ARVCF PTPRS MTOR DIP2C PYGB GCN1 IQGAP3 TOP3A RASD2	1.87e-05	1105	163	17	35748872
Pubmed	Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8.	WRN SMARCA2 SMARCA4	2.16e-05	12	163	3	15140983
Pubmed	Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk.	PSEN1 PSEN2	2.18e-05	2	163	2	21285369
Pubmed	Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy.	PSEN1 PSEN2	2.18e-05	2	163	2	33973882
Pubmed	The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.	SMARCA2 SMARCA4	2.18e-05	2	163	2	8670841
Pubmed	Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12.	PSEN1 PSEN2	2.18e-05	2	163	2	12460542
Pubmed	The mucolipidosis IV Ca2+ channel TRPML1 (MCOLN1) is regulated by the TOR kinase.	MCOLN1 MTOR	2.18e-05	2	163	2	26195823
Pubmed	Alzheimer's Disease Associated Presenilin 1 and 2 Genes Dysregulation in Neonatal Lymphocytes Following Perinatal Asphyxia.	PSEN1 PSEN2	2.18e-05	2	163	2	34067945
Pubmed	Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.	BCAT1 MTOR	2.18e-05	2	163	2	28235484
Pubmed	RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum.	RASGRP1 RASD2	2.18e-05	2	163	2	27902448
Pubmed	Presenilins regulate synaptic plasticity in the perforant pathways of the hippocampus.	PSEN1 PSEN2	2.18e-05	2	163	2	36710361
Pubmed	Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.	SMARCA2 SMARCA4	2.18e-05	2	163	2	23163725
Pubmed	Binding of transcription factors to Presenilin 1 and 2 promoter cis-acting elements varies during the development of mouse cerebral cortex.	PSEN1 PSEN2	2.18e-05	2	163	2	27177724
Pubmed	Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts.	PSEN1 PSEN2	2.18e-05	2	163	2	11715026
Pubmed	Clinical Phenotype and Mutation Spectrum of Alzheimer's Disease with Causative Genetic Mutation in a Chinese Cohort.	PSEN1 PSEN2	2.18e-05	2	163	2	34102969
Pubmed	Cloning, genomic organization and expression pattern of a novel Drosophila gene, the disco-interacting protein 2 (dip2), and its murine homolog.	DIP2A DIP2C	2.18e-05	2	163	2	12137943
Pubmed	Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.	SMARCA2 SMARCA4	2.18e-05	2	163	2	23076393
Pubmed	Dysregulation of hypoxia-inducible factor by presenilin/γ-secretase loss-of-function mutations.	PSEN1 PSEN2	2.18e-05	2	163	2	23365231
Pubmed	Changes in cholesterol metabolism are associated with PS1 and PS2 gene regulation in SK-N-BE.	PSEN1 PSEN2	2.18e-05	2	163	2	17401156
Pubmed	Structure and expression of mouse aldolase genes. Brain-specific aldolase C amino acid sequence is closely related to aldolase A.	ALDOA ALDOC	2.18e-05	2	163	2	3009179
Pubmed	The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.	SMARCA2 SMARCA4	2.18e-05	2	163	2	15576411
Pubmed	Identification of Structural Calcium Binding Sites in Membrane-Bound Presenilin 1 and 2.	PSEN1 PSEN2	2.18e-05	2	163	2	32420742
Pubmed	Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro.	PSEN1 PSEN2	2.18e-05	2	163	2	33413468
Pubmed	Individual and combined presenilin 1 and 2 knockouts reveal that both have highly overlapping functions in HEK293T cells.	PSEN1 PSEN2	2.18e-05	2	163	2	31167792
Pubmed	Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.	SMARCA2 SMARCA4	2.18e-05	2	163	2	15240517
Pubmed	Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.	SMARCA2 SMARCA4	2.18e-05	2	163	2	26564006
Pubmed	SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.	SMARCA2 SMARCA4	2.18e-05	2	163	2	33027072
Pubmed	Presenilin regulates extracellular regulated kinase (Erk) activity by a protein kinase C alpha dependent mechanism.	PSEN1 PSEN2	2.18e-05	2	163	2	18367332
Pubmed	A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.	SMARCA2 SMARCA4	2.18e-05	2	163	2	23872584
Pubmed	Dominant negative effect of the loss-of-function γ-secretase mutants on the wild-type enzyme through heterooligomerization.	PSEN1 PSEN2	2.18e-05	2	163	2	29078389
Pubmed	Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria.	PSEN1 PSEN2	2.18e-05	2	163	2	19834068
Pubmed	Genetic dissection of gamma-secretase-dependent and -independent functions of presenilin in regulating neuronal cell cycle and cell death.	PSEN1 PSEN2	2.18e-05	2	163	2	18971484
Pubmed	Presenilin Gene Mutation-associated Psychosis: Phenotypic Characteristics and Clinical Implications.	PSEN1 PSEN2	2.18e-05	2	163	2	38227890
Pubmed	Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.	SMARCA2 SMARCA4	2.18e-05	2	163	2	23088494
Pubmed	Epigenetic regulation of presenilin 1 and 2 in the cerebral cortex of mice during development.	PSEN1 PSEN2	2.18e-05	2	163	2	25652771
Pubmed	Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.	MTOR RASD2	2.18e-05	2	163	2	25556834
Pubmed	Loss of presenilin function enhances tau phosphorylation and aggregation in mice.	PSEN1 PSEN2	2.18e-05	2	163	2	34593029
Pubmed	SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.	SMARCA2 SMARCA4	2.18e-05	2	163	2	20333683
Pubmed	Loss of Spatial Memory, Learning, and Motor Function During Normal Aging Is Accompanied by Changes in Brain Presenilin 1 and 2 Expression Levels.	PSEN1 PSEN2	2.18e-05	2	163	2	25204494
Pubmed	Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology.	PSEN1 MTOR	2.18e-05	2	163	2	24411482
Pubmed	SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.	SMARCA2 SMARCA4	2.18e-05	2	163	2	34812766
Pubmed	Aldolase-B knockout in mice phenocopies hereditary fructose intolerance in humans.	ALDOA ALDOB	2.18e-05	2	163	2	25637246
Pubmed	Increased inflammatory response both in brain and in periphery in presenilin 1 and presenilin 2 conditional double knock-out mice.	PSEN1 PSEN2	2.18e-05	2	163	2	19584449
Pubmed	Presenilins regulate synaptic plasticity and mitochondrial calcium homeostasis in the hippocampal mossy fiber pathway.	PSEN1 PSEN2	2.18e-05	2	163	2	28619096
Pubmed	Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.	PSEN1 PSEN2	2.18e-05	2	163	2	8574969
Pubmed	Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.	SMARCA2 SMARCA4	2.18e-05	2	163	2	30478150
Pubmed	In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand.	PSEN1 PSEN2	2.18e-05	2	163	2	12846562
Pubmed	Cerebral organoids derived from patients with Alzheimer's disease with PSEN1/2 mutations have defective tissue patterning and altered development.	PSEN1 PSEN2	2.18e-05	2	163	2	37864790
Pubmed	Ibuprofen partially attenuates neurodegenerative symptoms in presenilin conditional double-knockout mice.	PSEN1 PSEN2	2.18e-05	2	163	2	24699228
Pubmed	The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.	SMARCA2 SMARCA4	2.18e-05	2	163	2	25808524
Pubmed	Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.	SMARCA2 SMARCA4	2.18e-05	2	163	2	19144648
Pubmed	Presenilin-directed inhibitors of gamma-secretase trigger caspase 3 activation in presenilin-expressing and presenilin-deficient cells.	PSEN1 PSEN2	2.18e-05	2	163	2	15287885
Pubmed	A sequence within the first transmembrane domain of PEN-2 is critical for PEN-2-mediated endoproteolysis of presenilin 1.	PSEN1 PSEN2	2.18e-05	2	163	2	15537629
Pubmed	Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin.	PSEN1 PSEN2	2.18e-05	2	163	2	12885769
Pubmed	Age and sex dependent alteration in presenilin expression in mouse cerebral cortex.	PSEN1 PSEN2	2.18e-05	2	163	2	17874292
Pubmed	Chromatin remodeler BRM is a key mediator of leucine-stimulated mTOR gene transcription in mouse mammary epithelial cells.	MTOR SMARCA2	2.18e-05	2	163	2	36587526
Pubmed	Presenilin-1/γ-secretase controls glutamate release, tyrosine phosphorylation, and surface expression of N-methyl-D-aspartate receptor (NMDAR) subunit GluN2B.	PSEN1 GRIN2B	2.18e-05	2	163	2	24025330
Pubmed	Two homologous genes causing early-onset familial Alzheimer's disease.	PSEN1 PSEN2	2.18e-05	2	163	2	9246482
Pubmed	A {gamma}-secretase-independent mechanism of signal transduction by the amyloid precursor protein.	PSEN1 PSEN2	2.18e-05	2	163	2	16103124
Pubmed	High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.	SMARCA2 SMARCA4	2.18e-05	2	163	2	29391527
Pubmed	Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.	SMARCA2 SMARCA4	2.18e-05	2	163	2	37634210
Pubmed	Dimorphic effects of Notch signaling in bone homeostasis.	PSEN1 PSEN2	2.18e-05	2	163	2	18297084
Pubmed	Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice.	PSEN1 PSEN2	2.18e-05	2	163	2	15128703
Pubmed	Polar transmembrane-based amino acids in presenilin 1 are involved in endoplasmic reticulum localization, Pen2 protein binding, and γ-secretase complex stabilization.	PSEN1 PSEN2	2.18e-05	2	163	2	21914807
Pubmed	Environment enrichment rescues the neurodegenerative phenotypes in presenilins-deficient mice.	PSEN1 PSEN2	2.18e-05	2	163	2	17614943
Pubmed	Presenilin1 inhibits glioblastoma cell invasiveness via promoting Sortilin cleavage.	PSEN1 SORT1	2.18e-05	2	163	2	34781973
Pubmed	Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction.	PSEN1 PSEN2	2.18e-05	2	163	2	20854432
Pubmed	PSEN1 and PSEN2 gene expression in Alzheimer's disease brain: a new approach.	PSEN1 PSEN2	2.18e-05	2	163	2	24927704
Pubmed	Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.	SMARCA2 SMARCA4	2.18e-05	2	163	2	8208605
Pubmed	Abnormalities in periodontal and salivary tissues in conditional presenilin 1 and presenilin 2 double knockout mice.	PSEN1 PSEN2	2.18e-05	2	163	2	20953898
Pubmed	Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1.	PSEN1 PSEN2	2.18e-05	2	163	2	22002539
Pubmed	mTOR Regulation of N-Myc Downstream Regulated 1 (NDRG1) Phosphorylation in Clear Cell Renal Cell Carcinoma.	NDRG1 MTOR	2.18e-05	2	163	2	37298315
Pubmed	Presence of presenilin 1/2 affects the invasion and replication of Salmonella typhimurium.	PSEN1 PSEN2	2.18e-05	2	163	2	15922300
Pubmed	Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice.	PSEN1 PSEN2	2.18e-05	2	163	2	18539391
Pubmed	Presenilin mutations in Alzheimer's disease.	PSEN1 PSEN2	2.18e-05	2	163	2	9521418
Pubmed	Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein.	PSEN1 PSEN2	2.18e-05	2	163	2	9450754
Pubmed	The mechanism of γ-Secretase dysfunction in familial Alzheimer disease.	PSEN1 PSEN2	2.18e-05	2	163	2	22505025
Pubmed	Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation.	PSEN1 PSEN2	2.18e-05	2	163	2	9298903
Pubmed	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.	SMARCA2 SMARCA4	2.18e-05	2	163	2	11163203
Pubmed	Circadian rhythm sleep disorders and time-of-day-dependent memory deficiency in Presenilin1/2 conditional knockout mice with long noncoding RNA expression profiling changes.	PSEN1 PSEN2	2.18e-05	2	163	2	36805914
Pubmed	Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.	SMARCA2 SMARCA4	2.18e-05	2	163	2	12620226
Pubmed	BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.	SMARCA2 SMARCA4	2.18e-05	2	163	2	27039070
Pubmed	Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.	SMARCA2 SMARCA4	2.18e-05	2	163	2	29848589
Pubmed	Familial frontotemporal dementia-associated presenilin-1 c.548G>T mutation causes decreased mRNA expression and reduced presenilin function in knock-in mice.	PSEN1 PSEN2	2.18e-05	2	163	2	22496554
Pubmed	Novel role of presenilins in maturation and transport of integrin beta 1.	PSEN1 PSEN2	2.18e-05	2	163	2	18293935
Pubmed	gamma-Secretase complexes containing N- and C-terminal fragments of different presenilin origin retain normal gamma-secretase activity.	PSEN1 PSEN2	2.18e-05	2	163	2	16135086
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	FRAS1 ADGRB3 ABCA10 MAGI2 FBLN1 FBXL7 PTPRS PRKD1	6.31e-07	195	163	8	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Sepsis-URO-Lymphocyte-T/NK-Treg\|URO / Disease, condition lineage and cell class	ANKRD31 MAN2C1 UFSP2 GCNT4 MYCBPAP ABCA10 PASK OSBP2	6.56e-07	196	163	8	8812d7365fb2b33feff93782d60776e932499a43
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	ADGRB3 ABCA10 MAGI2 FBLN1 FBXL7 PTPRS DIP2C PRKD1	6.81e-07	197	163	8	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	DMGDH PDZD7 RYR3 RGS6 CLCNKA MYOM2 SPOCD1	2.39e-06	163	163	7	1e8730d75cccf7292010683ab4e81a69d8e3bfa9
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 MYO7B GRIN2B TEX11 RYR3 ARFGEF3 MYOM2	5.31e-06	184	163	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 MYO7B GRIN2B TEX11 RYR3 ARFGEF3 MYOM2	5.31e-06	184	163	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 MYO7B GRIN2B TEX11 RYR3 ARFGEF3 MYOM2	5.31e-06	184	163	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 EML6 GPRC5C GCNT4 RASGRP1 NDRG1 HS6ST1	6.78e-06	191	163	7	0a0719a0a49ae0099d61e22585ac74c10c24b4a2
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ADGRB3 VIT ABCA10 TMEM132C FBXL7 PTPRS ADGRD1	6.78e-06	191	163	7	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FRAS1 ADGRB3 ABCA10 FBLN1 FBXL7 PTPRS PRKD1	6.78e-06	191	163	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	FRAS1 WRN WDR59 NDRG1 PRKD1 ADGRD1 HSP90AA1	7.02e-06	192	163	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FRAS1 ADGRB3 ABCA10 FBLN1 FBXL7 PTPRS PRKD1	7.02e-06	192	163	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK9 ADGRB3 PLXND1 RYR3 FBXL7 SYT11 CDH5	7.26e-06	193	163	7	2e72309607902dabe3218888b22a77fe941f3570
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	ADGRB3 VIT ABCA10 FBLN1 FBXL7 PTPRS ADGRD1	7.51e-06	194	163	7	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ADGRB3 VIT ABCA10 FBLN1 FBXL7 PTPRS ADGRD1	7.76e-06	195	163	7	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	facs-Thymus-nan-3m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STRBP ABCC5 PLXND1 RASGRP1 ANO6 HS6ST1 SMARCA4	7.76e-06	195	163	7	79114b3c78cc15c413bb58f0673e7215b784a9b6
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	ADGRB3 VIT ABCA10 FBLN1 FBXL7 PTPRS PRKD1	7.76e-06	195	163	7	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRB3 ABCA10 TMEM132C MAGI2 FBLN1 FBXL7 PTPRS	8.03e-06	196	163	7	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ADGRB3 ABCA10 TMEM132C FBLN1 FBXL7 PTPRS PRKD1	8.03e-06	196	163	7	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	ADGRB3 ABCA10 TMEM132C MAGI2 FBLN1 FBXL7 PTPRS	8.86e-06	199	163	7	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Neuronal-Excitatory-eF(C1QL3)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCHS2 VIT SSTR2 RASGRP1 NDRG1 PRKD1 MYOM2	9.15e-06	200	163	7	7668ae7ed550583ab59e419c5c9bb9f2d7e8e0d5
ToppCell	Neuronal-Excitatory-eF(C1QL3)----L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCHS2 VIT SSTR2 RASGRP1 NDRG1 PRKD1 MYOM2	9.15e-06	200	163	7	44f0278cb0e4ffcda4af3719d7f5819a10929b9f
ToppCell	Neuronal-Excitatory-eF(C1QL3)---\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCHS2 VIT SSTR2 RASGRP1 NDRG1 PRKD1 MYOM2	9.15e-06	200	163	7	23da7790e09575b2ca909ed16806b44223bf1017
ToppCell	Neuronal-Excitatory-eF(C1QL3)-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCHS2 VIT SSTR2 RASGRP1 NDRG1 PRKD1 MYOM2	9.15e-06	200	163	7	91f3df1c5a661ff703835f58a35cee93f18eb15c
ToppCell	Neuronal-Excitatory-eF(C1QL3)--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCHS2 VIT SSTR2 RASGRP1 NDRG1 PRKD1 MYOM2	9.15e-06	200	163	7	2e2b1d252972b702ade25526ec8461bf613d81b0
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	DMGDH VIT RYR3 TMEM132C MYOM2 ADGRD1	2.76e-05	160	163	6	8a41e2c96e0e170ac35daf6c403bf961b8d7c30b
ToppCell	TCGA-Bladder-Solid_Tissue_Normal\|TCGA-Bladder / Sample_Type by Project: Shred V9	DMGDH VIT RYR3 TMEM132C MYOM2 ADGRD1	2.76e-05	160	163	6	d6678996e12eaf2b735f1dfae32418cb2fabf268
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	DMGDH VIT RYR3 TMEM132C MYOM2 ADGRD1	2.76e-05	160	163	6	c8dc575562b463fd30832d322c28006f18f7ab9c
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LDHC ARFGEF3 LIMK1 PYGB NME6 ALDOC	2.86e-05	161	163	6	9f02b94e29e60d50e92eaa748ebf0c36d3671bb3
ToppCell	NS-critical-d_0-4-Epithelial-FOXN4+\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GPRC5C NCDN TYMS SHF PTPRS DIP2C	4.13e-05	172	163	6	a00bb44d33658cb3a98accd6b60f3ce964c425b4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VIT ABCA10 FBLN1 ADRA1D PTPRS ADGRD1	4.55e-05	175	163	6	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 VIT SSTR2 RASGRP1 PRKD1 MYOM2	4.70e-05	176	163	6	0710689e66deba179b0a8038cdd56b4834984f12
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DNAJC13 DOLK LANCL1 ARFGEF3 ARVCF TOP3A	4.85e-05	177	163	6	e1e45956887371b1c18f1eb479dd930031497520
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 VIT SSTR2 RASGRP1 PRKD1 MYOM2	5.00e-05	178	163	6	6f61490d79cd1727ed2d5cc673823dd4efdafac1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 VIT SSTR2 RASGRP1 RGS6 MYOM2	5.16e-05	179	163	6	1ac79c82c52fa95bb4e170ab20fec0f648db2134
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	ADGRB3 VIT ABCA10 FBLN1 FBXL7 PTPRS	5.16e-05	179	163	6	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 EML6 GRIN2B NDRG1 HS6ST1 BNIPL	5.33e-05	180	163	6	023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 SSTR2 RASGRP1 RGS6 NDRG1 MYOM2	5.49e-05	181	163	6	9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112
ToppCell	COVID-19-kidney-Stressed_PCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DMGDH MYO7B SSTR2 EHHADH ALDOB ACSM2B	5.49e-05	181	163	6	6980ea624151da32b7f537f263e40fcb87a02e81
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GABRG2 SSTR2 ARFGEF3 MTMR7 POTEJ PERCC1	5.84e-05	183	163	6	8820cfed27b292bc0bc9cde4005219ed41900552
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	VIT ABCA10 TMEM132C FBLN1 FBXL7 PTPRS	6.02e-05	184	163	6	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADGRB3 VIT ABCA10 FBLN1 FBXL7 ADGRD1	6.20e-05	185	163	6	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	VIT ABCA10 MAGI2 FBLN1 FBXL7 PTPRS	6.20e-05	185	163	6	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 DOCK9 HIPK2 MYCBPAP SMARCA2 CDH5	6.58e-05	187	163	6	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	FRAS1 ADGRB3 FBLN1 FBXL7 PTPRS PRKD1	6.58e-05	187	163	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADGRB3 VIT ABCA10 FBLN1 FBXL7 ADGRD1	6.77e-05	188	163	6	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 EML6 GRIN2B RASGRP1 NDRG1 HS6ST1	6.98e-05	189	163	6	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 PLXND1 RYR3 FBXL7 GSE1 CDH5	7.18e-05	190	163	6	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VIT ABCA10 FBLN1 FBXL7 PTPRS ADGRD1	7.18e-05	190	163	6	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GABRG2 SSTR2 ARFGEF3 MTMR7 POTEJ PERCC1	7.18e-05	190	163	6	5f1863bce9400b7c932f0e4d0e012ec4e8d7e555
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FASTKD1 WRN SLC25A37 SLC22A16 SND1-IT1 IQGAP3	7.18e-05	190	163	6	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EML6 GRIN2B GCNT4 NDRG1 HS6ST1 BNIPL	7.18e-05	190	163	6	078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	ADGRB3 VIT ABCA10 FBLN1 FBXL7 PTPRS	7.61e-05	192	163	6	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 EML6 GRIN2B NDRG1 HS6ST1 SMARCA2	7.61e-05	192	163	6	fd08ae787e936cfdb1ab8f19b0fd63005b462709
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIWIL1 ADGRB3 PLXND1 RYR3 FBXL7 CDH5	7.61e-05	192	163	6	25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 EML6 GRIN2B NDRG1 HS6ST1 SMARCA2	7.61e-05	192	163	6	bae236c9f1fac77bce28d0a9cf090100d391ff77
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 TBC1D5 MAGI2 DIP2C VPS13B ACSM2B	7.61e-05	192	163	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FASTKD1 WRN SLC25A37 SLC22A16 SND1-IT1 IQGAP3	7.61e-05	192	163	6	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Naive_CD4+_T\|T/NK_cells / Location, Cell class and cell subclass	PFDN5 GCNT4 COMMD6 PASK EIF3H TMEM63A	7.83e-05	193	163	6	1778342a7f546dbc8c1f7875aa505345e72ee765
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VIT ABCA10 TMEM132C ADRA1D RGS6 ADGRD1	7.83e-05	193	163	6	549a0b750c860b615aff767ad04c9a9d20f802f0
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRB3 TMEM132C MAGI2 FBLN1 PTPRS PRKD1	7.83e-05	193	163	6	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	TMEM132C MAGI2 FBLN1 FBXL7 DIP2C PRKD1	7.83e-05	193	163	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC5 PLXND1 RASGRP1 ANO6 HS6ST1 SMARCA4	7.83e-05	193	163	6	a6a864644e1b80b7417ea0a27281e79068a3fd3d
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	FRAS1 WRN WDR59 NDRG1 ADGRD1 HSP90AA1	7.83e-05	193	163	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	FRAS1 ADGRB3 TMEM132C MAGI2 FBLN1 PTPRS	7.83e-05	193	163	6	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA10 TMEM132C MAGI2 FBLN1 FBXL7 PTPRS	7.83e-05	193	163	6	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 PLXND1 RYR3 FBXL7 GSE1 CDH5	7.83e-05	193	163	6	287e756d5fd3bd2931c168da24beaa0d02a350ae
ToppCell	facs-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC5 HNRNPF RASGRP1 ANO6 HS6ST1 SMARCA4	8.06e-05	194	163	6	f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	ADGRB3 VIT ABCA10 FBLN1 FBXL7 PTPRS	8.06e-05	194	163	6	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	facs-Thymus-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC5 HNRNPF RASGRP1 ANO6 HS6ST1 SMARCA4	8.06e-05	194	163	6	cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB3 TMEM132C MAGI2 FBLN1 PTPRS PRKD1	8.06e-05	194	163	6	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	facs-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC5 HNRNPF RASGRP1 ANO6 HS6ST1 SMARCA4	8.06e-05	194	163	6	66c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCell	TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1\|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9	HNRNPF PASK LIMK1 FBXL7 SLC25A19 CDH5	8.06e-05	194	163	6	eaeeb84576270cc3fc59002ba33bff9639bb0b02
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK9 ADGRB3 PLXND1 RYR3 FBXL7 CDH5	8.29e-05	195	163	6	77e47d2e8b3eb7f7c9620369ccaf87581f923bdb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 PLXND1 RYR3 FBXL7 GSE1 CDH5	8.52e-05	196	163	6	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRG2 STRBP EML6 ADGRB3 COPG2 GRIN2B	8.52e-05	196	163	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 TYMS ARFGEF3 DYNLRB2 CMAHP LMNTD1	8.52e-05	196	163	6	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 TYMS ARFGEF3 DYNLRB2 CMAHP LMNTD1	8.52e-05	196	163	6	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 PLXND1 RYR3 FBXL7 GSE1 CDH5	8.52e-05	196	163	6	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK9 ADGRB3 PLXND1 RYR3 FBXL7 CDH5	8.52e-05	196	163	6	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	ADGRB3 MAGI2 FBLN1 FBXL7 DIP2C PRKD1	8.76e-05	197	163	6	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK9 ADGRB3 PLXND1 FBXL7 GSE1 CDH5	8.76e-05	197	163	6	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VIT ABCA10 TMEM132C FBLN1 FBXL7 PTPRS	8.76e-05	197	163	6	3bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VIT ABCA10 TMEM132C FBLN1 FBXL7 PTPRS	8.76e-05	197	163	6	17344464fdcc5ba0c03959696b97c195f11e644c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 PLXND1 RYR3 FBXL7 GSE1 CDH5	8.76e-05	197	163	6	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	Bronchial-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VIT TMEM132C RGS6 NDRG1 OR2AT4 ADGRD1	8.76e-05	197	163	6	ee8f7def9d5af7b1e636830a4ea1da158d02f25a
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VIT ABCA10 TMEM132C FBLN1 FBXL7 PTPRS	8.76e-05	197	163	6	5b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK9 ADGRB3 PLXND1 RYR3 FBXL7 CDH5	9.01e-05	198	163	6	07701c73137947ed4a27e225975329235bbb8734
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRG2 STRBP EML6 ADGRB3 COPG2 GRIN2B	9.01e-05	198	163	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	FRAS1 ADGRB3 ABCA10 FBLN1 PTPRS PRKD1	9.01e-05	198	163	6	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	DMGDH DNAH3 ADGB EML5 DYNLRB2 LMNTD1	9.01e-05	198	163	6	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	GABRG2 GRIN2B PLXND1 SSTR2 ARFGEF3 NDRG1	9.01e-05	198	163	6	d81f35c0066558ff96dd06f58fca72cd82e681e8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK9 ADGRB3 PLXND1 RYR3 FBXL7 CDH5	9.01e-05	198	163	6	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 PLXND1 RYR3 FBXL7 GSE1 CDH5	9.01e-05	198	163	6	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANKRD31 DNAH3 ADGB DYNLRB2 SPOCD1 LMNTD1	9.26e-05	199	163	6	15f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 ADGRB3 ABCA10 FBLN1 FBXL7 PTPRS	9.52e-05	200	163	6	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRB3 ABCA10 TMEM132C FBLN1 FBXL7 PTPRS	9.52e-05	200	163	6	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Rgs14_(CA2_Principal_cells)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	VIT CLCNKA MYOM2 SPOCD1	1.07e-04	67	163	4	771fc7c4917b5dc5ebf1b7be304d62902f0b75cc
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Rgs14_(CA2_Principal_cells)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	VIT CLCNKA MYOM2 SPOCD1	1.07e-04	67	163	4	f56d8787ab2170997d28a2f66d83b4c18362b97d
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOLK PASK SHF SLC25A19 TANGO6	1.39e-04	135	163	5	0e5dfbe79598fc7822a7b3baa8d7dba3c9da1dad
Drug	chloroacetol phosphate	PFDN5 ALDOA ALDOB ALDOC	3.66e-08	6	162	4	CID000168137
Drug	amorphin	PYGB ALDOA ALDOB ALDOC	1.69e-07	8	162	4	CID000122792
Drug	acetol phosphate	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000150865
Drug	4-hydroxy-9-fluorenone	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000016139
Drug	Htfp	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000125055
Drug	DIDIT	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000196082
Drug	2-keto-3-deoxy- l-lyxonate	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000192781
Drug	(4S,7R,8R,9R,13Z,16S)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-1-oxacyclohexadec-13-ene-2,6-dione	PFDN5 ALDOA ALDOC	3.54e-07	3	162	3	CID009869661
Drug	androisoxazole	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000009676
Drug	2-keto-3-bromobutyrate	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000191968
Drug	3-isochromanone	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000078092
Drug	5-deoxy-5-fluoro-L-sorbose	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000191809
Drug	D-ribulose-1-p	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000000615
Drug	4-hydroxy-2-ketopimelate	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000000553
Drug	AC1L19F1	ALDOA ALDOB ALDOC	3.54e-07	3	162	3	CID000000519
Drug	formylacetate	ALDOA ALDOB ALDOC	1.41e-06	4	162	3	CID000075269
Drug	dihydroxyacetone sulfate	ALDOA ALDOB ALDOC	1.41e-06	4	162	3	CID000439751
Drug	C06441	ALDOA ALDOB ALDOC	1.41e-06	4	162	3	CID000441020
Drug	3-hydroxy-1-indanone	ALDOA ALDOB ALDOC	1.41e-06	4	162	3	CID000176448
Drug	l-123	ALDOA ALDOB ALDOC	1.41e-06	4	162	3	CID000093552
Drug	selenazofurin	NMNAT1 TYMS MAGI2 NDRG1 SMARCA2	2.51e-06	31	162	5	CID000100665
Drug	ketose	PSEN2 SLC22A16 ALDOA ALDOB ALDOC	2.51e-06	31	162	5	CID000439494
Drug	1,3-dioxan-5-one	ALDOA ALDOB ALDOC	3.50e-06	5	162	3	CID009793707
Drug	AC1L4F2K	ALDOA ALDOB ALDOC	3.50e-06	5	162	3	CID000184526
Drug	gamma-oxalocitramalate	ALDOA ALDOB ALDOC	3.50e-06	5	162	3	CID000000130
Drug	2,3-dihydroxy-p-cumate	ALDOA ALDOB ALDOC	3.50e-06	5	162	3	CID000029587
Drug	AC1NX490	ALDOA ALDOB ALDOC	3.50e-06	5	162	3	CID005743230
Drug	phosphoglycollamide	ALDOA ALDOB ALDOC	3.50e-06	5	162	3	CID000191768
Drug	D-erythrulose 1-phosphate	ALDOA ALDOB ALDOC	3.50e-06	5	162	3	CID000152153
Drug	hydroxypyruvaldehyde phosphate	ALDOA ALDOB ALDOC	3.50e-06	5	162	3	CID000193787
Drug	mycestericin D	ALDOA ALDOB ALDOC	6.96e-06	6	162	3	CID006439504
Drug	C02783	ALDOA ALDOB ALDOC	6.96e-06	6	162	3	CID000439805
Drug	2,2-dimethyl-1,3-dioxan-5-one	ALDOA ALDOB ALDOC	6.96e-06	6	162	3	CID002733141
Drug	2-(N-decyl)aminonaphthalene-6-sulfonic acid	ALDOA ALDOB ALDOC	6.96e-06	6	162	3	CID000189836
Drug	parapyruvate	ALDOA ALDOB ALDOC	6.96e-06	6	162	3	CID000440249
Drug	acetyldithio-CoA	ALDOA ALDOB ALDOC	6.96e-06	6	162	3	CID003082679
Drug	0 Gz	ALDOA ALDOB ALDOC	6.96e-06	6	162	3	CID000000372
Drug	deoxyribose 5-phosphate	TYMS PYGB ALDOA ALDOB ALDOC	1.04e-05	41	162	5	CID000000635
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A_EA	MAN2C1 PSEN2 APBA3 PLXND1 WDR59 PTPRS ALDOC TOP3A TMEM63A	1.13e-05	195	162	9	1015_UP
Drug	acenaphthenone	ALDOA ALDOB ALDOC	1.21e-05	7	162	3	CID000075229
Drug	DAPpNP	ALDOA ALDOB ALDOC	1.21e-05	7	162	3	CID005492375
Drug	5-deoxy-D-xylulose-1-phosphate	ALDOA ALDOB ALDOC	1.21e-05	7	162	3	CID000192931
Drug	Z-Glu-Tyr	ALDOA ALDOB ALDOC	1.21e-05	7	162	3	CID000096820
Drug	C0447	ALDOA ALDOB ALDOC	1.21e-05	7	162	3	CID000128786
Drug	3-hydroxy-4-oxobutyl-1-phosphonate	ALDOA ALDOB ALDOC	1.93e-05	8	162	3	CID003016813
Drug	L-rhamnulose-1-phosphate	ALDOA ALDOB ALDOC	1.93e-05	8	162	3	CID000439413
Drug	magnesium	DNAH3 MAN2C1 PNMT NMNAT1 WRN BCAT1 PFDN5 GRIN2B ITGB3 LDHC GFM2 RYR3 TYMS ARHGAP1 PASK CLCNKA DYNLRB2 PRKD1 NME6 ZDHHC13 TOP3A DGAT1 HSP90AA1 SOS2	2.30e-05	1325	162	24	CID000000888
Drug	2-oxopentenoate	ALDOA ALDOB ALDOC	2.88e-05	9	162	3	CID000000976
Drug	tartronate semialdehyde	ALDOA ALDOB ALDOC	4.09e-05	10	162	3	CID000001122
Drug	SM-8	ALDOA ALDOB ALDOC	4.09e-05	10	162	3	CID000486037
Drug	L-fuconic acid	TYMS ALDOA ALDOC	4.09e-05	10	162	3	CID000345732
Drug	xylonate	TYMS ALDOA ALDOC	4.09e-05	10	162	3	CID000010264
Drug	Ichiba acid	ALDOA ALDOC	5.03e-05	2	162	2	CID000440403
Drug	3-HM	ALDOA ALDOC	5.03e-05	2	162	2	CID000439464
Drug	bromohydroxyacetone phosphate	ALDOA ALDOC	5.03e-05	2	162	2	CID000152675
Drug	S-182	PSEN1 PSEN2	5.03e-05	2	162	2	CID003033995
Drug	10-Propargyl-5,8-Dideazafolic Acid	TYMS NQO2	5.03e-05	2	162	2	DB03541
Drug	anthracene diol	ALDOA ALDOC	5.03e-05	2	162	2	CID000155464
Drug	1-o-phosphonohex-2-ulose	PYGB ALDOA ALDOB ALDOC	5.11e-05	29	162	4	CID000000481
Drug	troglitazone; Down 200; 10uM; HL60; HT_HG-U133A	DNAH3 DOLK HIPK2 BCAT1 PLXND1 NCDN NDRG1 SOS2	7.22e-05	192	162	8	1173_DN
Drug	1trd	ALDOA ALDOB ALDOC	7.42e-05	12	162	3	CID000004797
Drug	dihydropteridine	ALDOA ALDOB ALDOC	7.42e-05	12	162	3	CID000000167
Drug	AC1Q5BXE	TYMS ALDOA ALDOB ALDOC	7.60e-05	32	162	4	CID000000037
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	ABCC5 WDR59 BLVRA EHHADH CNPY3 NME6 VPS13B TOP3A	8.04e-05	195	162	8	6927_DN
Drug	NSC403510	WRN TYMS PYGB ALDOA ALDOB ALDOC	8.58e-05	101	162	6	CID000345751
Drug	CGS 9343B	PRKD1 ALDOA ALDOB ALDOC	8.60e-05	33	162	4	CID000065909
Drug	Tenax	TEP1 ALDOA ALDOB ALDOC	8.60e-05	33	162	4	CID000122082
Drug	Aldol	BCAT1 ALDOA ALDOB ALDOC	8.60e-05	33	162	4	CID000007897
Drug	Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	APBA3 LANCL1 WDR59 SLC25A37 NCDN BLVRA FBLN1 ADRA1D	8.64e-05	197	162	8	3230_DN
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A	TBC1D5 HIPK2 APBA3 YTHDC2 SLC25A37 BLVRA PASK FBLN1	8.95e-05	198	162	8	7544_UP
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; MCF7; HT_HG-U133A	RPS6KA4 TEP1 BLVRA ARHGAP1 ARVCF SMARCA2 TOP3A TMEM63A	8.95e-05	198	162	8	2653_DN
Drug	Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A	RPS6KA4 YTHDC2 PLXND1 WDR59 SLC25A37 ASB7 CNPY3 TOP3A	8.95e-05	198	162	8	7416_DN
Drug	Chlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	GABRG2 DOCK9 HIPK2 PLXND1 PASK ADRA1D ARVCF SMARCA2	8.95e-05	198	162	8	3198_DN
Drug	Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A	PSEN1 YTHDC2 MCOLN1 NCDN BLVRA FBLN1 LIMK1 OSBP2	8.95e-05	198	162	8	4697_UP
Drug	Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	PSEN2 DOCK9 HIPK2 SORT1 BLVRA FBXL7 MTOR TMEM63A	8.95e-05	198	162	8	3415_UP
Drug	Nitrocaramiphen hydrochloride; Down 200; 10.8uM; MCF7; HT_HG-U133A	CEP104 PSEN2 HIPK2 NCDN LIMK1 EHHADH TMEM63A SOS2	8.95e-05	198	162	8	6504_DN
Drug	Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; HL60; HT_HG-U133A	PSEN1 PDZD7 WDR59 ARHGAP1 FBLN1 ADRA1D RGS6 SOS2	9.26e-05	199	162	8	1277_UP
Drug	Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A	MAN2C1 PSEN2 TBC1D5 TRMO WDR59 PASK SMARCA4 TMEM63A	9.26e-05	199	162	8	7398_DN
Drug	Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	PSEN2 TBC1D5 ITGB3 SLC25A37 BLVRA ARVCF PTPRS SOS2	9.26e-05	199	162	8	5545_UP
Drug	alpha-ketobutyrate	BCAT1 LDHC ALDOA ALDOB ALDOC	9.31e-05	64	162	5	CID000000058
Drug	1,6-di-o-phosphonohexopyranose	EXOSC1 PYGB ALDOA ALDOB ALDOC	9.31e-05	64	162	5	CID000000737
Drug	fuculose	ALDOA ALDOB ALDOC	9.60e-05	13	162	3	CID000000841
Drug	hydroxybutanone	MAN2C1 ALDOA ALDOC	1.22e-04	14	162	3	CID000521300
Drug	beta-isopropyl-tropolone	ALDOA ALDOB ALDOC	1.22e-04	14	162	3	CID000080297
Drug	2-keto-4-hydroxyglutarate	ALDOA ALDOB ALDOC	1.22e-04	14	162	3	CID000000599
Drug	3,3,3-trifluoropropanoic acid	ALDOA ALDOC	1.50e-04	3	162	2	CID002777972
Drug	4-fluorothreonine	ALDOA ALDOC	1.50e-04	3	162	2	CID000128057
Drug	AC1L19ID	ALDOA ALDOC	1.50e-04	3	162	2	CID000000560
Drug	C11 -427	ALDOA ALDOC	1.50e-04	3	162	2	CID000443195
Drug	thiopental	GABRG2 RYR3 NDRG1 PYGB PRKD1 HSP90AA1	1.52e-04	112	162	6	CID003000715
Drug	ribose-5-P	SMARCA2 SMARCA4 PYGB ALDOA ALDOB ALDOC	1.52e-04	112	162	6	CID000439167
Drug	pteridine	TYMS AP1G1 ALDOA ALDOB ALDOC	1.53e-04	71	162	5	CID000001043
Drug	sulforhodamine B	SSTR2 TYMS NQO2 TOP3A HSP90AA1	1.74e-04	73	162	5	CID000065191
Drug	AC1L1JGQ	RPS6KA4 HIPK2 MTOR PRKD1 HSP90AA1	1.74e-04	73	162	5	CID000005034
Drug	glycidaldehyde	ALDOA ALDOB ALDOC	1.85e-04	16	162	3	CID000013002
Drug	DIDP	TYMS PYGB NME6 TOP3A	2.04e-04	41	162	4	CID000439488
Drug	trimethylaminobutyraldehyde	ALDOA ALDOB ALDOC	2.23e-04	17	162	3	CID000000133
Drug	methyl acetimidate	PNMT ALDOA ALDOC	2.23e-04	17	162	3	CID000026888
Drug	3HPP	ALDOA ALDOB ALDOC	2.23e-04	17	162	3	CID000000091
Drug	AC1Q3UIN	ITGB3 TYMS PYGB	2.23e-04	17	162	3	CID000128986
Disease	Colorectal Carcinoma	DNAH3 CACUL1 WRN ABCC5 ZNF217 ABCA10 NCDN TYMS GSE1 PTPRS DIP2C PRKD1 EIF3H VWA2 CDH5	5.19e-06	702	156	15	C0009402
Disease	Epileptic encephalopathy	GRIN2B RYR3 MAGI2 MTOR	1.85e-05	30	156	4	C0543888
Disease	Alzheimer's disease 3 (implicated_via_orthology)	PSEN1 PSEN2	2.78e-05	2	156	2	DOID:0110042 (implicated_via_orthology)
Disease	hypoglycemia (biomarker_via_orthology)	PNMT GRIN2B	8.30e-05	3	156	2	DOID:9993 (biomarker_via_orthology)
Disease	apolipoprotein B measurement	ANKRD31 DCHS2 DNAJC13 PSEN1 GCNT4 ABCA10 SORT1 AP1G1 SMARCA4 CNPY3 PYGB CMAHP	2.23e-04	663	156	12	EFO_0004615
Disease	Schizophrenia	GABRG2 RAPGEF6 PSEN2 GRIN2B ITGB3 MAGI2 ARHGAP1 EML5 ARVCF SYT11 MTOR SMARCA2 NQO2 RASD2	2.62e-04	883	156	14	C0036341
Disease	West Syndrome	GRIN2B MAGI2 CNPY3	2.70e-04	24	156	3	C0037769
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 SMARCA4	2.75e-04	5	156	2	C3281201
Disease	early-onset Parkinson's disease (implicated_via_orthology)	PSEN1 PSEN2	4.11e-04	6	156	2	DOID:0060894 (implicated_via_orthology)
Disease	Asphyxia Neonatorum	PSEN1 PSEN2	4.11e-04	6	156	2	C0004045
Disease	Early-onset autosomal dominant Alzheimer disease	PSEN1 PSEN2	5.73e-04	7	156	2	cv:CN043596
Disease	Malignant neoplasm of breast	MAN2C1 STRBP MCOLN1 TYMS CLPTM1L NDRG1 MTOR DIP2C FASTKD3 ALDOA NQO2 SPOCD1 CDH5 VPS13B HSP90AA1	5.98e-04	1074	156	15	C0006142
Disease	Colorectal Neoplasms	CACUL1 ABCC5 ABCA10 TYMS PRKD1 EIF3H CDH5	7.06e-04	277	156	7	C0009404
Disease	Alzheimer disease	PSEN1 PSEN2	7.62e-04	8	156	2	cv:C0002395
Disease	X-17676 measurement	DNAH3 ACSM2B	7.62e-04	8	156	2	EFO_0800785
Disease	sporadic amyotrophic lateral sclerosis	LDHC RGS6 GSE1 MYOM2 ADGRD1	9.10e-04	140	156	5	EFO_0001357
Disease	HbA1c measurement	CEP104 PSEN1 TRMO SLC25A37 OR51E2 RASGRP1 SLC22A16 CMAHP TOP3A DGAT1 SOS2	9.66e-04	675	156	11	EFO_0004541
Disease	underweight body mass index status	ADGRB3 RGS6	9.76e-04	9	156	2	EFO_0005936
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCA4	9.76e-04	9	156	2	DOID:0050340 (implicated_via_orthology)
Disease	Carcinoma, Small Cell	MTOR SMARCA4	9.76e-04	9	156	2	C0262584
Disease	Autism Spectrum Disorders	GRIN2B ITGB3 DIP2A IQGAP3	1.09e-03	85	156	4	C1510586
Disease	Optic Atrophy	SLC25A46 NMNAT1	1.22e-03	10	156	2	C0029124
Disease	Amyloidosis	PSEN1 ZDHHC13	1.22e-03	10	156	2	C0002726
Disease	cervical cancer	MAGI2 CLPTM1L PRKD1	1.24e-03	40	156	3	MONDO_0002974
Disease	sleep duration, low density lipoprotein cholesterol measurement	ANKRD31 GPRC5C MAGI2 SMARCA4	1.41e-03	91	156	4	EFO_0004611, EFO_0005271
Disease	Neuroendocrine Tumors	SSTR2 TYMS	1.48e-03	11	156	2	C0206754
Disease	Memory Loss	PSEN1 MAGI2 NQO2	1.53e-03	43	156	3	C0751295
Disease	Age-Related Memory Disorders	PSEN1 MAGI2 NQO2	1.53e-03	43	156	3	C0751292
Disease	Memory Disorder, Spatial	PSEN1 MAGI2 NQO2	1.53e-03	43	156	3	C0751294
Disease	Memory Disorder, Semantic	PSEN1 MAGI2 NQO2	1.53e-03	43	156	3	C0751293
Disease	Memory Disorders	PSEN1 MAGI2 NQO2	1.53e-03	43	156	3	C0025261
Disease	uric acid measurement	DNAH3 FRAS1 DNAJC13 RPS6KA4 QRICH2 SHF DIP2C PYGB ACSM2B SOS2	1.57e-03	610	156	10	EFO_0004761
Disease	Memory impairment	PSEN1 MAGI2 NQO2	1.64e-03	44	156	3	C0233794
Disease	Familial dilated cardiomyopathy	PSEN1 PSEN2 DOLK	1.64e-03	44	156	3	C0340427
Disease	Thromboembolism	OR51E2 OR52A4P OR51V1	1.64e-03	44	156	3	HP_0001907
Disease	Neurobehavioral Manifestations	NMNAT1 MAGI2	1.77e-03	12	156	2	C0525041
Disease	hemoglobin A1 measurement	CACUL1 TRMO PLXND1 SLC25A37 RASGRP1 SLC22A16 ARVCF DGAT1 SOS2	1.86e-03	520	156	9	EFO_0007629
Disease	Coffin-Siris syndrome	SMARCA2 SMARCA4	2.08e-03	13	156	2	C0265338
Disease	ocular hypertension, response to triamcinolone acetonide	CES5A ZNF217 TMEM132C	2.23e-03	49	156	3	EFO_0006954, EFO_1001069
Disease	phospholipids in IDL measurement	ANKRD31 ABCA10 SMARCA4	2.65e-03	52	156	3	EFO_0022164
Disease	lower face morphology measurement	DCHS2 YTHDC2 MYOM2 VPS13B	2.72e-03	109	156	4	EFO_0010948
Disease	lysophosphatidylethanolamine 18:0 measurement	FBXL7 TNR	2.79e-03	15	156	2	EFO_0010367
Disease	RS-10-hydroxywarfarin to RS-warfarin ratio measurement	FRAS1 RGS6 ASB7 RASD2	2.81e-03	110	156	4	EFO_0803335
Disease	hepatocellular carcinoma (is_implicated_in)	TEP1 RYR3 TYMS CLPTM1L SMARCA4	2.81e-03	181	156	5	DOID:684 (is_implicated_in)
Disease	heel bone mineral density, urate measurement	ANKRD31 EML6 WRN CHD1L MYOM2	2.88e-03	182	156	5	EFO_0004531, EFO_0009270
Disease	Small cell carcinoma of lung	NDRG1 SMARCA4 DIP2C	2.95e-03	54	156	3	C0149925
Disease	Metastatic melanoma	PASK MTOR PRKD1	2.95e-03	54	156	3	C0278883
Disease	mean platelet volume	NUP210L TBC1D5 EML6 ABCC5 TRMO ZNF217 PLXND1 MCOLN1 ITGB3 SLC25A37 COMMD6 GSE1 CMAHP	3.08e-03	1020	156	13	EFO_0004584
Disease	lifestyle measurement, alcohol consumption measurement	ADRA1D RGS6 ASB7 PRKD1	3.30e-03	115	156	4	EFO_0007878, EFO_0010724
Disease	prostate specific antigen measurement	TEX11 FBXO46 SLC25A37 CLPTM1L FBLN1	3.31e-03	188	156	5	EFO_0004624
Disease	Astrocytosis	ITGB3 TNR	3.59e-03	17	156	2	C3887640
Disease	banks of the superior temporal sulcus volume measurement	AP1G1 SMARCA2	3.59e-03	17	156	2	EFO_0010286
Disease	Gliosis	ITGB3 TNR	3.59e-03	17	156	2	C0017639
Disease	triglycerides to total lipids in small VLDL percentage	ANKRD31 DMGDH SMARCA4	3.61e-03	58	156	3	EFO_0022338
Disease	food allergy measurement, parental genotype effect measurement	DCHS2 EML6	4.02e-03	18	156	2	EFO_0005939, EFO_0007016
Disease	response to opioid	SLC25A37 TMEM132C TNR	4.17e-03	61	156	3	EFO_0008541
Disease	abnormal paneth cell measurement	FBLN1 ADRA1D	4.48e-03	19	156	2	EFO_0007963
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	TEP1 HSP90AA1	4.48e-03	19	156	2	DOID:4928 (is_marker_for)
Disease	serum metabolite measurement	DMGDH PSEN2 BCAT1 MAGI2 ADRA1D GSE1 SLC22A16 TRIM56 DIP2C MYOM2 SPOCD1 ACSM2B	4.54e-03	945	156	12	EFO_0005653
Disease	triglycerides to total lipids in medium VLDL percentage	ANKRD31 DMGDH SMARCA4	4.56e-03	63	156	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	ANKRD31 DMGDH SMARCA4	4.56e-03	63	156	3	EFO_0022239
Disease	X-24309 measurement	DNAJC13 ADRA1D	4.96e-03	20	156	2	EFO_0800872
Disease	response to vaccine, cytokine measurement	DCHS2 DNAH3 GRIN2B DIP2C	5.24e-03	131	156	4	EFO_0004645, EFO_0004873

Protein segments in the cluster

Peptide	Gene	Start	Entry
IHMLKGISIYPETLS	SYT11	56	Q9BT88
YMFEEVPIVIKNSHL	EIF3H	196	O15372
DVHTVRKMLEQGYSP	ASB7	26	Q9H672
LSSYEPLKMVIIDHG	ARVCF	471	O00192
SDILYKGETIHIPTM	BCAT1	341	P54687
IELPKKYHEMVGVIF	ABCA10	26	Q8WWZ4
LVEGLHLYSMVIKVF	ADGRD1	651	Q6QNK2
FLVHQDMILVPKVYT	ADGB	1011	Q8N7X0
GMETLPHERLLHYKV	ADGRB3	1331	O60242
HVYLEGTLLKPNMVT	ALDOC	221	P09972
HVYLEGTLLKPNMVT	ALDOB	221	P05062
YPGIAHRMQKEITAL	POTEKP	306	Q9BYX7
HIYLEGTLLKPNMVT	ALDOA	221	P04075
GVHLKDLISLYEAMP	RASGRP1	356	O95267
LSMLHYIRGAAPKDI	GSE1	986	Q14687
LTEAYGEVHIKTMPA	APBA3	546	O96018
GEVHIKTMPAATYRL	APBA3	551	O96018
LIIGQPIAVLMYVHD	DGAT1	461	O75907
PTVGDHASVMYQILK	CDH5	181	P33151
VAEKHIYSLMPLLLE	CACUL1	256	Q86Y37
RGLYPTEEIQIAMKH	QRICH2	1576	Q9H0J4
QGYIFPISDHVLTMK	RGS6	91	P49758
VLGPYHVKFRSLSMV	MCOLN1	446	Q9GZU1
RILKNLIMSGYSPEH	AP1G1	221	O43747
EVLCTYAEIMHIKLP	ANO6	131	Q4KMQ2
AVLGSDTVHQMKPYL	ANKRD31	1641	Q8N7Z5
ISKPLHYVTIMSRGQ	OR4D11	126	Q8NGI4
HEIMVAPDKEYLLIV	DYNLRB2	76	Q8TF09
EAAIHPPYLVSKELM	PASK	1211	Q96RG2
SYIGRPIHLDKILMS	PRKD1	251	Q15139
HVDTGRMKIYTELPA	FRAS1	2061	Q86XX4
KHAGYSVRMENAVPI	HIPK2	671	Q9H2X6
IPVAGKTHRYVIDLM	MAGI2	831	Q86UL8
IIYIMKHSLSVGEVI	DOLK	151	Q9UPQ8
AGPLAVAAVLYHKMN	LANCL1	111	O43813
SVMKEAIGAVIHYLL	NCDN	366	Q9UBB6
LDPHYRTLKGFMVLI	MTMR7	356	Q9Y216
DMTVIEPYKKVLSHG	BNIPL	191	Q7Z465
PAHVMKLLEVIPSQY	EHHADH	436	Q08426
LTSSMYVPGKLHDVE	PFDN5	66	Q99471
HYKIPEGASLAMSLI	PLXND1	1641	Q9Y4D7
QYMLLLPEHVLVKIF	FBXO46	471	Q6PJ61
SLHPIVRVVMGDIYL	OR51E2	266	Q9H255
GTPMALIVISYIHVA	OR3A1	211	P47881
HILAVLVLYIPMVGV	OR51Q1	246	Q8NH59
YIPIISLTMVHRFGK	OR51V1	261	Q9H2C8
IIIKSEPSLHEPMYI	OR52A4P	51	A6NMU1
QTHIMLTIKETGRYP	PDZD7	281	Q9H5P4
LTLERKYGHITPMAQ	PERCC1	196	A0A1W2PR82
RPVILTYHDIGMNHK	NDRG1	56	Q92597
HKAIMESGVAIIPYL	CES5A	246	Q6NT32
NPEDKGYVLHMITTA	DRAM2	196	Q6UX65
IMKSIIPAIVHYSPD	LDHC	116	P07864
FMKTLDGVYAVHPQL	LRRC74A	376	Q0VAA2
ELPALKYLDMGTTHI	LRRC37B	676	Q96QE4
VYSLVHFSPKMLGSV	LMNTD1	16	Q8N9Z9
RFAKVHILYVGSMPL	EXOSC1	81	Q9Y3B2
CTMLGKLFEPYVVHV	GCN1	1446	Q92616
IEYMAPEIIRSKTGH	RPS6KA4	201	O75676
VTFGIKHSDYMTPLL	ODF3	236	Q96PU9
IAPFGLIYILLKHMV	TMEM63A	631	O94886
MAGKKVLIVYAHQEP	NQO2	1	P16083
KYISIMPLGAIHLEF	OSBP2	656	Q969R2
PYVAVMLKVADHSGQ	COMMD6	41	Q7Z4G1
GRVPTEDYMSHIIEK	HS6ST1	396	O60243
KPMVYITVGELVNTH	IQGAP3	1276	Q86VI3
PEKTVDVYGHVTLMR	PTPRS	1611	Q13332
PLDYEMKTQHILTVL	DCHS2	1681	Q6V1P9
ALMHKVPSEGAYDII	GPRC5C	376	Q9NQ84
IVGPFHAVLKLEMNY	FBLN1	666	P23142
GPAFMVKHLLEYTQA	ABCC5	196	O15440
AIRKHYGEAVVEPEM	CEP104	386	O60308
LKYIPSVLHDVEMVF	DOCK2	796	Q92608
VLKGILHEAAMQYPK	DOCK9	446	Q9BZ29
QIDETRMGYKPVAVH	DNAH3	3286	Q8TD57
RMGYKPVAVHSATIF	DNAH3	3291	Q8TD57
PAVREFIAEHMGKLY	DNAH3	3486	Q8TD57
FIAEHMGKLYIEAPT	DNAH3	3491	Q8TD57
FPIAYSLVVHKDAIM	GCNT4	131	Q9P109
PLHGKQISIRYLDMT	FBXL7	266	Q9UJT9
GIYAVVHLLLPVMSV	ARFGEF3	1496	Q5TH69
LVHKGVKVVMDIPYE	CNPY3	136	Q9BT09
PKKTEVVIYHGMSAL	CHD1L	271	Q86WJ1
HLYFSPLMGKIADIV	FASTKD1	166	Q53R41
GVKPTLIHTDMYVNS	GABRG2	86	P18507
HVISIPYSLMKVNPL	DIP2C	561	Q9Y2E4
LTVSVPGMEKALHQY	COPG2	551	Q9UBF2
GKHVLVEYPMTLSLA	BLVRA	91	P53004
PILVEKVAILLYHIM	DNAJC13	1096	O75165
NISHMLTPKGRVYAE	DMGDH	566	Q9UI17
VMDYHLETRKPVLGQ	MAN2C1	741	Q9NTJ4
LPMFGYKHVLTLTDQ	ITGB3	211	P05106
IKAVHTTKELYAGMP	HEATR1	1086	Q9H583
PYVPDKLITAGIKHM	EML5	826	Q05BV3
YAVSIREMEGTKPHQ	EML6	1311	Q6ZMW3
LRKHGLEVIYMIEPI	HSP90AA1	511	P07900
HVVSVPYALMKANPL	DIP2A	576	Q14689
AMIFHDIPGVVKTYR	NUP210L	1536	Q5VU65
LVAVVAEPSLHKPMY	OR2AT4	51	A6NND4
HIMGNVVYAILTPIL	OR2AT4	276	A6NND4
LGMLVSFVKSHIRPY	MTOR	1016	P42345
IPLKLVMIVGIDCYH	PIWIL1	621	Q96J94
VSVVHLPIVYKGSMT	SND1-IT1	91	Q9HBX3
VHMRGLPYKATENDI	HNRNPF	291	P52597
HVPLVIMTFGQSKLY	SORT1	131	Q99523
LPTYIGSMIKLHVVP	SERAC1	591	Q96JX3
MRIYSGTIKPQLAIH	GFM2	386	Q969S9
ITPTLDKQYMHGIVR	RAPGEF6	346	Q8TEU7
GGTVVKLIERLTYHM	SOS2	601	Q07890
ALITYLMEHKRLNGP	SMARCA2	761	P51531
KYGAKHVIMLFVPVT	PSEN1	76	P49768
YLSRPKVQVLFHIMG	TMEM132C	141	Q8N3T6
ALACGVVMVIPQKHY	SLC22A16	426	Q86VW1
VVMVIPQKHYILGVV	SLC22A16	431	Q86VW1
VVQIPYHEIGMLKSR	FASTKD3	626	Q14CZ7
GILEHSVMYPVDSVK	SLC25A37	56	Q9NYZ2
KALYIVHPTMFIKTL	ARHGAP1	156	Q07960
GILTLKYPMEHGIIT	POTEJ	726	P0CG39
ALITYLMEHKRINGP	SMARCA4	791	P51532
LHVAVKVLQAMGYPT	STRBP	441	Q96SI9
YPSIITDHFVVKAAM	OR56A3	136	Q8NH54
ADIRQVIHYGAPKDM	WRN	831	Q14191
YLIHMAIEILKHGPD	WRN	1346	Q14191
VMVIYGAVALHAPKK	MROH2B	701	Q7Z745
MSIDRYLAVVHPIKS	SSTR2	136	P30874
SVKLLEYMAHIAPEV	BCL2L15	116	Q5TBC7
VGVRHSLKYPAIMTE	ADRA1D	196	P25100
YRIGPSEVENALMKH	ACSM2B	471	Q68CK6
VHPEMDTCIIVEYKG	CMAHP	161	Q9Y471
GKQVHLVSPLTTYMV	CLPTM1L	121	Q96KA5
VGPFVHLSVMIAAYL	CLCNKA	166	P51800
KYMKGTSIVVPEPLH	UFSP2	186	Q9NUQ7
YIMPAHLQTGVDDVK	PNMT	256	P11086
IKGAEHMSLLYPVAI	SHF	406	Q7M4L6
DMIHGTPVLDIKPYI	TRMO	146	Q9BU70
LEKVSPIFMLHFVEG	USPL1	411	Q5W0Q7
HMPIIAYLISKGQSV	ZDHHC13	161	Q8IUH4
LASVPKFYVQVLHLM	RNPC3	176	Q96LT9
TENPMILSTHKEYGI	TEP1	2411	Q99973
PVHFKTFVMGLILVI	SEC62	191	Q99442
EHLLLKSLTYVVAMP	SLC25A46	201	Q96AG3
HKAPMVLFLDRVYGI	RYR3	2361	Q15413
LRALKMIHPYVIDTS	REXO5	316	Q96IC2
KVVHGDVTPYDLVRM	SPOCD1	681	Q6ZMY3
KRHAVLMGLQPATEY	TNR	826	Q92752
APGYHMAKLIIKLVT	PYGB	611	P11216
ELEEITGSPKHVMVY	VWA2	486	Q5GFL6
ALLTYMIAHITGLKP	TYMS	231	P04818
ALGDMVSKYREPLIH	TANGO6	946	Q9C0B7
IPAMAAHLKGVITYA	VIT	611	Q6UXI7
PLVMGKYTQSLHSEV	MYCBPAP	901	Q8TBZ2
MASGPIRAYILAHKD	NME6	76	O75414
LKYGAKHVIMLFVPV	PSEN2	81	P49810
MSPALHRKISVQYGD	RASD2	196	Q96D21
TIAIIAMEKPAHYPL	TEX11	776	Q8IYF3
HIETIKARMYVGLTP	TOP3A	541	Q13472
LSAYHTGLIAPMKIR	WDR59	576	Q6PJI9
AGMVLDPEHFNYIVK	TOPAZ1	1231	Q8N9V7
LIQHSVIHTGEMPYK	ZNF550	386	Q7Z398
VKAALVAGMYPNLVH	YTHDC2	971	Q9H6S0
IKIISAGHKYMEPLQ	VPS13B	1121	Q7Z7G8
DLPKYHMVRGITSLL	ZNF217	941	O75362
IKHPVSLEQYLMEGS	PSMD8	226	P48556
LYKQGMHELLAPIVF	TBC1D5	201	Q92609
EPKVYNTLRHAVGTM	SLC25A19	151	Q9HC21
LTAYHGLEKPRVTTM	TRIM56	716	Q9BRZ2
VMVAGELKYHPECFI	LIMK1	96	P53667
PMSNLEKVHFIVGYA	MYO7B	1086	Q6PIF6
VTVSVYKHGEKIPDM	MYOM2	1431	P54296
FSEDGYQMHPKLVII	GRIN2B	351	Q13224
IPAYHRVIMAELATK	NMNAT1	61	Q9HAN9